glp-1 weight loss risks Supremo Nutrition GLP-1 Drugs and Eating Disorders:
Description
Fusion Proteins : Utilizing fusion partners like albumin or Fc fragments to increase the drug's molecular weight, reduce rapid renal filtration, and coordinate with other mechanisms to prolong circulation time in the body
Patients currently on Saxenda may want to discuss alternative options with their doctor as supply winds down
This led to further trials focused specifically on weight management
Cause 4: Dehydration Reduced appetite from GLP-1 medications does not just affect food intake it can also suppress thirst signals
